Study data suggest that cognitive impairments may be associate with worse survival among patients with hematologic cancer.
Data on psychosocial and psychiatric variables of patients with HNC prior to treatment was analyzed to determine the extent of cognitive impairment and quality of life for patients with head and neck cancer, and its impact on patient outcomes.
A double-blind study compared the effectiveness of lorazepam plus haloperidol with haloperidol alone in reducing agitation in patients with advanced cancer.
The researchers found that the majority of patients had no frank detectable cognitive impairment after undergoing skull base irradiation.
Moderate-to-vigorous physical activity was found to improve working memory and executive function in survivors of breast cancer.
In this study, researchers measured the psychological manifestations among patients with BCR-ABL-negative MPNs to determine the effects of anxiety, distress, and depression on symptom burden in this patient population.
Drug abuse may cause an unusual short-term memory syndrome
Researchers sought to evaluate the incidence of cancer-related cognitive impairment in patients with breast cancer in a large prospective, longitudinal, nationwide study. These findings address limitations in previous research.
Moderate physical activity can ease the stress that impairs memory among breast cancer survivors, research indicates.
Mindfulness-based Stress Reduction Reduces Cognitive Deficits in Survivors of Breast and Colorectal CancersDecember 24, 2015
Participation in an MBSR program yields robust and sustained improvement in cancer-related cognitive impairment.
There are benefits for breast and colorectal cancer survivors with mindfulness-based stress reduction, study data indicates.
Findings based on small study of childhood cancer survivors with treatment-related deficits shows benefits of computerized cognitive intervention.
Pretreatment cytokine levels are associated with reduced memory performance among newly diagnosed patients with post-menopausal breast cancer.
Breast cancer and chemobrain: Stress of diagnosis can impair cognitive function before chemotherapy is startedMay 05, 2015
Milder cognitive defects displayed by breast cancer patient even before the initiation of chemotherapy may be attributable to disease-related posttraumatic stress, new study data indicates.
Do cancer treatments alter alleles affecting saliva, thus rendering a Genecept Assay null and void?
For patients undergoing chemotherapy for breast cancer, cognitive complaints after treatment may be associated with changes in brain activity, according to a study.
Adult and young adult cancer survivors face cognitive and sexual late effects from cancer and its treatment, according to data compiled from an online cancer survivorship care planning tool presented at the 2014 ASCO Annual Meeting.
Patients who express pretreatment concern about treatment symptoms such as nausea and memory problems tend to suffer higher symptom burdens during and after anticancer treatment, suggests research.
Cancer does not seem to affect pretreatment cognition in older women with breast cancer, compared to healthy controls; however, cognition may be affected in some subgroups of breast cancer patients.
Elderly with faster cognitive decline were found to have lower risk of cancer mortality, according to research.
Cognitive flexibility, verbal fluency, and processing speed were improved in women whose breast cancer had been treated with chemotherapy and who used exercises to improve executive function, according to a new study.
Pretreatment neurocognitive compromise and fatigue were key contributors to the cognitive effects that are often attributed to chemotherapy.
Sign Up for Free e-newsletters
- Real World Results May Not Mirror Clinical Study Outcomes in Multiple Myeloma
- Is Radioimmunotherapy a Path Forward for Melanoma?
- Handling Chemotherapy Premedications
- FDA Approves Mogamulizumab-kpkc for Rare Subtypes of Non-Hodgkin Lymphoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Seeking Reliable Information on Herbal Products
- Disparities Remain in Prevalence of Cancer Screening Tests
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- 8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
- Combined Digital Screening Best for Detecting Breast Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|